[18F]FDG PET in Breast Cancer: Exploratory Investigation of Clinicopathological Significance

[18F]FDG PET in Breast Cancer: Exploratory Investigation of Clinicopathological Significance - [18F]FDG PET in Breast Cancer: Exploratory Investigation of Clinicopathological Significance

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061127

Enrollment

400

Registered

2026-04-01

Start date

2022-03-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with breast cancer or suspected breast cancerr

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with confirmed or suspected breast cancer who underwent [18F]FDG PET imaging (using PET/CT, dedicated breast PET, and/or PET/MR) at the Department of Diagnostic Radiology, Kyoto University Hospital. Female patients aged 18 years or older.

Exclusion criteria

Exclusion criteria: Individuals judged unsuitable for the study by the Principal Investigator, Sub-investigator, or Co-investigator.

Design outcomes

Primary

Measure	Time frame
Elucidation of the clinicopathological significance of PET findings	—

Secondary

Measure	Time frame
Extraction and reproducibility of PET findings Optimization of PET image reconstruction methods Correlations with other imaging and clinical findings Application of advanced PET image processing and analysis	—

Countries

Japan

Contacts

Public ContactKanae Miyake

Kyoto University Hospital Department of Diagnostic Imaging and Nuclear Medicine

diag_rad@kuhp.kyoto-u.ac.jp075-751-4748

Outcome results